Drugs / GSK2190195
last change Jun 2010 re-read 3 minutes ago

GSK2190195

Developed for
asthma
Investigated by
GlaxoSmithKline

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00850642 Jun 2009 → Jun 2010 asthma GlaxoSmithKline Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GSK2190195 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00850642 ↗